Akouos (NASDAQ: AKUS) Enters Into Agreement to be Acquired by Eli Lilly (NYSE: LLY) at Valuation Up to $610 Million
Akouos, Inc. (NASDAQ: AKUS) is engaged as a precision genetic medicine company, which is focused on the research and development ...
Akouos, Inc. (NASDAQ: AKUS) is engaged as a precision genetic medicine company, which is focused on the research and development ...
Decibel Therapeutics, Inc. (NASDAQ: DBTX) is engaged as a clinical-stage biotechnology company, which is focused on the research and development ...
InnerScope Hearing Technologies, Inc. (OTCQB: INND) is engaged in the hearing aid industry with a series of B2B and B2C ...
Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.
Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.
Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.